7210 Wareham Drive, Tampa, FL 33647
Sept. 23, 2024 According to Becker’s Hospital Review… On Sept. 24, Novo Nordisk CEO Lars Fruergaard Jørgensen is slated to testify at a Senate committee hearing about the costs for Wegovy and Ozempic. The hearing comes after months of disagreements between Denmark-based Novo Nordisk and the Senate Committee on Health, Education, Labor and Pensions. The […]
GLP-1 Drugs Market Update Read More »
May 20, 2024 Medifast today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program. View the full release here: https://www.businesswire.com/news/home/20240520770526/en/ This will be an investment of up to $30 million in company-led marketing efforts. Medifast is committed
Medifast To Launch National Marketing Campaign Read More »
April 13, 2024 Marketdata LLC (parent company of DietBusinessWatch) has just released new research, a report entitled: “The Telehealth Weight Loss Market”. The market for weight loss programs delivered via telehealth / telemedicine companies is worth $6.9 billion, and growing. Telehealth soared during the pandemic in 2020 as consumers stayed home and communicated with their
Telehealth Weight Loss Market Worth $6.9 Billion And Growing Read More »
Feb. 28, 2024 WW reported its results for Q4 2023 and the full year today. WW reported results in line with analysts’ expectations in Q4 FY2023, with revenue down 8% year on year to $206 million. “2023 was a pivotal year as we began transforming our business for the future. We returned WeightWatchers to year
Weight Watchers Reports Q4 and 2023 Results Read More »
January 30, 2024 Based on the latest data from the ASMBS (American Society for Metabolic and Bariatric Surgery), the number of surgeries performed jumped by 32% in 2021, to 262,893. This happened during the pandemic, which is surprising, since many elective procedures were postponed. This was about 25% higher than Marketdata’s estimate in our March
Bariatric Surgery Volume Sees Big Increase In 2021 Read More »
November 2, 2023 WW reported results for its 3rd quarter. Management reported that: “We have successfully returned WeightWatchers to subscriber growth, with Q3 end of period subscribers up 6% year-over-year to 4.0 million. This is a significant achievement and a direct result of our work in reinvigorating our core product,” said Sima Sistani, the company’s
Weight Watchers Reports 3rd Quarter Results Read More »
March 20, 2023 Marketdata LLC, Tampa, FL, has just released it 17th Edition of its best-selling market research report: “The U.S. Weight Loss & Diet Control Market”. At 427 pages, with 160 Tables & Charts and 34 in-depth diet company competitor profiles, this is the most comprehensive analysis anywhere of the market. Some findings… The
Weight Loss Market Recovers to $75 Billion – New Marketdata Report Read More »
March 5, 2022 Marketdata’s new report, The U.S. Weight Loss Market: 2022 Status Report & Forecast (March 2022, 90 pp.) has just been released. Major Findings: The value of the U.S. weight loss market is estimated to have declined by a historic 25% in 2020, to $58 billion. as a result of closures of weight loss centers and
Weight Loss Market Rebounds in 2021 From 25% Decline in 2020 – New Report Read More »
Feb. 3, 2022 As reported here and in many other publications, Noom’s rapid growth as a weight loss program is well known. The company may plan an IPO this year, and it’s estimated that revenues topped $600 million last year. The company has raised $669 million to date. However, there may be some weak spots.
Dec. 30, 2021 2021 was a historic year for obesity treatment. In June, the Food and Drug Administration approved the weight loss drug semaglutide, which some experts described as a “game changer”. The medication, initially developed to treat Type 2 diabetes, was the first drug treatment to be approved by the FDA for weight management since 2014. Wegovy,
Semaglutide a Game Changer Drug? Read More »